Please assess the completion status of the following clinical trial:

Trial Title: TIME ASPIRIN: Chronotherapy With Aspirin for Reduction of Cardiovascular Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Use of low-dose aspirin (acetylsalicylic acid 80mg \[brand name: acetylsalicylic acid cardio TEVA\]\~)~* Patients using aspirin from an MDD ('Baxter')~* Capacity to give informed consent (IC)~Exclusion Criteria:~* Pregnancy~* Mental or physical disability to fulfil study requirements~* Insufficient knowledge of the Dutch language~* Patients currently participating in another (clinical) trial or study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- aspirin after awakening + placebo before bedtime (Type: OTHER): Acetylsalicylic acid 80 mg once daily, orally. Intake in de morning after awakening. Participants already use acetylsalicylic acid 80 mg once daily due to secondary prevention of cardiovascular disease.~Placebo tablet once daily will be added to their medication. The placebo tablet will be taken before bedtime, orally. The placebo is given throughout the study.
- placebo after awakening +aspirin before bedtime (Type: EXPERIMENTAL): Acetylsalicylic acid 80 mg once daily, orally. The time will be changed form morning to bedtime. Participants already use acetylsalicylic acid 80 mg once daily due to secondary prevention of cardiovascular disease.~Placebo tablet once daily will be added to their medication. The placebo tablet will be taken after awakening, orally. The placebo is given throughout the study.

Based on this trial design, predict the completion outcome and termination type (if applicable).